
FDA approves first AI tool to predict breast cancer risk
Fox News
Experts say the FDA's approval of Clairity's AI tool marks a significant advancement in breast cancer risk prediction, utilizing mammogram images for accurate assessments.
"This is the wave of the future. AI is going to be part of the equation, but it's not going to take over." Angelica Stabile is a lifestyle reporter for Fox News Digital.
In a press release, Clairity shared its plans to launch the AI platform across health systems through 2025.
More Related News













